Vaccination of myeloma patients with monoclonal immunoglobulin loaded dendritic cells:: preclinical and first clinical results of a phase I/II clinical trial

被引：0
|
作者：
Ocadlikova, D.
Zahradova, L.
Kovarova, L.
Smejkalova, J.
Pour, L.
Vidlakova, P.
Kyjovska, D.
Stejskalova, A.
Novotna, H.
Penka, M.
Michalek, J.
Hajek, R.
机构：
[1] Masaryk Univ, Cell Immunotherapy Ctr, Brno, Czech Republic
[2] Univ Hosp, Dept Hematooncol, Brno, Czech Republic
[3] Univ Hosp, Dept Pediat 1, Brno, Czech Republic
[4] Univ Hosp, Dept Clin Hematol, Brno, Czech Republic
[5] Univ Hosp, Dept Clin Biochem, Brno, Czech Republic
来源：
BLOOD REVIEWS | 2007年 / 21卷
关键词：
D O I：
10.1016/S0268-960X(07)70213-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S129 / S129
页数：1
相关论文
共 50 条
  • [11] Vaccination of hormone-refractory prostate cancer patients with peptide cocktail-loaded dendritic cells: clinical results of a phase I clinical trial
    不详
    EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (02) : 96 - 96
  • [12] Allogeneic dendritic cells fused with tumor cells:: Preclinical results and outcome of a first clinical phase I/II trial in patients with metastatic renal cell carcinoma.
    Märten, A
    Renoth, S
    Heinicke, T
    von Lilienfeld-Toal, M
    Schmidt-Wolf, IGH
    BLOOD, 2001, 98 (11) : 406A - 406A
  • [13] Results of the first phase I/II clinical vaccination trial with direct injection of mRNA
    Weide, Benjamin
    Carralot, Jean-Philippe
    Reese, Anne
    Scheel, Birgit
    Eigentler, Thomas Kurt
    Hoerr, Ingmar
    Rammensee, Hans-Georg
    Garbe, Claus
    Pascolo, Steve
    JOURNAL OF IMMUNOTHERAPY, 2008, 31 (02) : 180 - 188
  • [14] Vaccination of hormone-refractory prostate cancer patients with peptide cocktail-loaded dendritic cells:: Results of a phase I clinical trial
    Fuessel, S.
    Meye, A.
    Schmitz, M.
    Zastrow, S.
    Linne, C.
    Richter, K.
    Lobel, B.
    Hakenberg, O. W.
    Hoelig, K.
    Rieber, E. P.
    Wirth, M. P.
    EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (14) : 801 - 801
  • [15] Vaccination of hormone-refractory prostate cancer patients with peptide cocktail-loaded dendritic cells:: Results of a Phase I clinical trial
    Fuessel, Susanne
    Meye, Axel
    Schmitz, Marc
    Zastrow, Stefan
    Linne, Clemens
    Richter, Katja
    Loebel, Barbel
    Hakenberg, Oliver W.
    Hoelig, Kristina
    Rieber, E. Peter
    Wirth, Manfred P.
    PROSTATE, 2006, 66 (08): : 811 - 821
  • [16] VACCINATION OF CLL PATIENTS WITH AUTOLOGOUS DENDRITIC CELLS LOADED WITH APOPTOTIC BODIES (APO-DC): A PHASE I-II CLINICAL TRIAL
    Palma, M.
    Hansson, L.
    Adamson, L.
    Eriksson, I.
    Nasman-Glaser, B.
    Widen, K.
    Choudhury, A. R.
    Osterborg, A.
    Mellstedt, H.
    ANNALS OF ONCOLOGY, 2008, 19 : 164 - 164
  • [17] Allogeneic dendritic cells fused with tumor cells:: Preclinical results and outcome of a clinical phase I/II trial in patients with metastatic renal cell carcinoma
    Märten, A
    Renoth, S
    Heinicke, T
    Albers, P
    Pauli, A
    Mey, U
    Caspari, R
    Flieger, D
    Hanfland, P
    Von Ruecker, A
    Eis-Hübinger, AM
    Müller, S
    Schwaner, I
    Lohmann, U
    Heylmann, G
    Sauerbruch, T
    Schmidt-Wolf, IGH
    HUMAN GENE THERAPY, 2003, 14 (05) : 483 - 494
  • [18] Vaccination of hormone-refractory prostate cancer patients with peptide cocktail-loaded dendritic cells:: Results of a phase I clinical trial.
    Fuessel, S
    Meye, A
    Schmitz, M
    Zastrow, S
    Linné, C
    Richter, K
    Hakenberg, OW
    Rieber, EP
    Wirth, MP
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9120S - 9120S
  • [19] Vaccination of hormone-refractory prostate cancer patients with peptide cocktail-loaded dendritic cells: Results of a phase I clinical trial.
    Meye, A.
    Fuessel, S.
    Schmitz, M.
    Zastrow, S.
    Linne, C.
    Richter, K.
    Lobel, B.
    Hakenberg, O. W.
    Hoelig, K.
    Rieber, P. E.
    Wirth, M. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 112S - 112S
  • [20] Vaccination of hormone-refractory prostate cancer patients with peptide cocktail-loaded dendritic cells: Immunological results of a phase I clinical trial
    不详
    EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (02) : 162 - 162
12345